Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

NCT02070458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Adult Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions

DRUG: ixazomib
DRUG: mitoxantrone hydrochloride
DRUG: etoposide
DRUG: cytarabine

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]